{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:53:27Z","timestamp":1791266007988,"version":"4.1.0"},"reference-count":26,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,3,29]]},"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Mortality due to liver disease (of which cirrhosis is the end stage) is increasing more than any other chronic condition in the UK. This study aims to demonstrate that (1) exclusive reliance on mortality rates may not reveal the true burden of liver cirrhosis, and (2) diverse use of diagnostic coding may produce misleading estimates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>The Office for National Statistics death registry was interrogated to investigate liver cirrhosis mortality trends in England and Wales from 1968 to 2011.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome<\/jats:title>\n                    <jats:p>Standardised mortality trends according to three different definitions of liver cirrhosis based on the specificity of diagnostic codes were calculated: 1 (chronic liver diseases), 2 (alcoholic and unspecified cirrhosis only) and 3 (cirrhosis as end-stage liver disease). The mortality trends were compared with incidence rates established in a previous population-based study (based on definition 3), from 1998 to 2009, to investigate discrepancies between these two measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over the study period, the overall standardised liver cirrhosis mortality rates were 8.8, 5,1 and 5.4 per 100\u2009000 person-years for definitions 1, 2 and 3, respectively. The mortality rates for definition 3 in 1998 and 2009 were 6.2 and 5.9 per 100\u2009000 person-years, respectively; while the equivalent incidence rates were at least threefold and sixfold higher: 23.4 and 35.9 per 100\u2009000 person-years, respectively. This discrepancy between incidence and mortality rates was also at least threefold in men and women separately and across age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Mortality rates underestimated the incidence of liver cirrhosis by at least threefold between 1998 and 2009 and varied with differing definitions of disease. Mortality data should not be used exclusively as an indicator for the occurrence of liver cirrhosis in the population. Routinely collected healthcare data are available to measure occurrence of this disease. Careful consideration should be taken when selecting diagnostic codes for cirrhosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-013752","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T20:10:17Z","timestamp":1500063017000},"page":"e013752","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Liver cirrhosis in England\u2014an observational study: are we measuring its burden occurrence correctly?"],"prefix":"10.1136","volume":"7","author":[{"given":"Sonia","family":"Ratib","sequence":"first","affiliation":[{"name":"Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"West","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate M","family":"Fleming","sequence":"additional","affiliation":[{"name":"Public Health Institute, Liverpool John Moores University, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"key":"2025121300124091000_7.7.e013752.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61838-9"},{"key":"2025121300124091000_7.7.e013752.2","unstructured":"CMO report 2012 (Internet). https:\/\/www.gov.uk\/government\/publications\/cmo-annual-report-2011-volume-one. (accessed 6 Feb 2016)."},{"key":"2025121300124091000_7.7.e013752.3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.405"},{"key":"2025121300124091000_7.7.e013752.4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/apt.13657","article-title":"Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability","volume":"44","author":"von Wulffen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121300124091000_7.7.e013752.5","unstructured":"Smith L , Foxcroft D . Drinking in the UK, an exploration of Trends. Joseph Rowntree Foundation, 2009."},{"key":"2025121300124091000_7.7.e013752.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60200-2"},{"key":"2025121300124091000_7.7.e013752.7","unstructured":"Alcohol: minimum pricing. http:\/\/www.parliament.uk\/business\/publications\/research\/briefing-papers\/SN05021\/alcohol-minimum-pricing. (accessed 7 May 2015)."},{"key":"2025121300124091000_7.7.e013752.8","unstructured":"Chronic management:Management of patients with Chronic Liver Diseases. http:\/\/www.bsg.org.uk\/clinical\/commissioning-report\/management-of-patients-with-chronic-liver-diseases.html. (accessed 6 Feb 2016)."},{"key":"2025121300124091000_7.7.e013752.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.09.027"},{"key":"2025121300124091000_7.7.e013752.10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ajg.2015.191","article-title":"Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study","volume":"110","author":"Ratib","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2025121300124091000_7.7.e013752.11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.058636"},{"key":"2025121300124091000_7.7.e013752.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22341"},{"key":"2025121300124091000_7.7.e013752.13","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1016\/j.cein.2006.09.003","article-title":"Diagnosis and management of alcoholic liver disease, a review","volume":"9","author":"SriRajaskanthan","year":"2006","journal-title":"Clin Eff Nurs"},{"key":"2025121300124091000_7.7.e013752.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)67924-5"},{"key":"2025121300124091000_7.7.e013752.15","unstructured":"WHO. http:\/\/www.who.int\/classifications\/icd\/en\/ (accessed 6 Feb 2016)."},{"key":"2025121300124091000_7.7.e013752.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c912"},{"key":"2025121300124091000_7.7.e013752.17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-8-3"},{"key":"2025121300124091000_7.7.e013752.18","unstructured":"ICD version 8. http:\/\/www.wolfbane.com\/icd\/icd8.htm. (accessed 6 Feb 2016)."},{"key":"2025121300124091000_7.7.e013752.19","unstructured":"ICD version 9. http:\/\/en.wikipedia.org\/wiki\/List_of_ICD-9_codes. (accessed 6 Feb 2016)."},{"key":"2025121300124091000_7.7.e013752.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.05.008"},{"key":"2025121300124091000_7.7.e013752.21","unstructured":"Liver disease in Wales. https:\/\/assemblyinbrief.wordpress.com\/2015\/05\/11\/liver-disease-in-wales. (accessed 6 Feb 2016)."},{"key":"2025121300124091000_7.7.e013752.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.005"},{"issue":"suppl1","key":"2025121300124091000_7.7.e013752.23","first-page":"280","article-title":"Is the CPRD GOLD population comparable to the U.K. population?","volume":"22","author":"Campbell","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025121300124091000_7.7.e013752.24","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.148031"},{"key":"2025121300124091000_7.7.e013752.25","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/20.1.199"},{"key":"2025121300124091000_7.7.e013752.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.01.025"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-013752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:12:48Z","timestamp":1765613568000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-013752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,13]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1136\/bmjopen-2016-013752"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-013752","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}